Private Equity, VC & Investor
Founders Fund vs Vitruvian Partners
Structured technology and market comparison · 2026
Direct Feature Comparison
Founders Fund · vs · Vitruvian PartnersVenture capital firm investing from early to late stage.
Private equity firm backing higher-growth companies across Europe and the US.
Analyze all overlapping signals and tech stacks for Founders Fund and Vitruvian Partners
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Founders Fund and Vitruvian Partners?
When comparing Founders Fund and Vitruvian Partners, both platforms operate within the Private Equity, VC & Investor ecosystem. Founders Fund is positioned as Venture capital firm investing from early to late stage, whereas Vitruvian Partners focuses on Private equity firm backing higher-growth companies across Europe and the US. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Founders Fund and Vitruvian Partners?
When evaluating Founders Fund and Vitruvian Partners, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Founders Fund and Vitruvian Partners compare?
Founders Fund is headquartered in US (founded in 2005) with 50–200 employees. Vitruvian Partners is based in GB (founded in 2006) with 50–200 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Founders Fund vs Vitruvian Partners
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Founders Fund
Recent Signals
- ·Trending Topics (DACH/CEE Innovation & Tech)Financials
Trade Republic Revenue Hits €754M, Profit Nearly 7-Fold
German neobroker Trade Republic reported revenue of €754 million for fiscal year 2024/25 (ending September 2025), with net profit surging from €34.8 million to €232.6 million, a nearly sevenfold increase. Commission income from securities trading more than doubled to €733 million. The company now serves over 10 million customers and manages €150 billion in assets. In December 2025, a secondary transaction valued the company at €12.5 billion, raising €1.2 billion from investors including Founders Fund, GIC, Fidelity, Wellington, and the Arnault family. These results precede the EU-wide ban on payment for order flow (PFOF) effective July 2026, a key revenue driver. Trade Republic has adapted with best-price execution across 30 trading venues, while facing declining interest income and a legal settlement with a consumer protection agency over advertising claims.
- Trade Republic reported €754 million revenue and €232.6 million net profit for FY 2024/25 (ending September 2025).
- Commission income from securities trading more than doubled to €733 million.
- Trade Republic reached over 10 million customers and €150 billion in assets under management by end of 2025.
- ·Trending Topics (DACH/CEE Innovation & Tech)AI Regulation
Peter Thiel Attacks AI Regulation in Nashville Lectures
In a four-part lecture series on the Antichrist held in Nashville, billionaire and Palantir co-founder Peter Thiel criticized AI regulation, calling it evil and accusing Pope Leo XIV and Barack Obama of exploiting AI fears for political gain. Thiel argued that such regulation could lead to a totalitarian world government, linking his views to his personal theology in which the Antichrist stops science. He also criticized the effective altruism movement for 'brainwashing' AI workers. Recordings of the first two lectures, with $100 tickets, were obtained by Politico. The Vatican and Pope Leo XIV have warned of AI's dehumanizing potential. Thiel's financial interests in AI, including Palantir and a $418 million AI-focused portfolio at Thiel Macro, are notable.
- Peter Thiel gave lectures in Nashville criticizing AI regulation, according to Politico recordings.
- Thiel accused Pope Leo XIV and Barack Obama of leveraging AI fears for their own popularity.
- Thiel described AI as 'the threat über alles of late modernity' in his lectures.
- ·Trending Topics (DACH/CEE Innovation & Tech)Funding
European Defense Tech Funding to Hit $10.5B Record
European defense tech startups have raised $7.4B in venture capital this year, nearly triple all of 2025 ($2.6B), according to the 'State of Defence Tech 2026' report by Dealroom and Resilience Media. The report projects year-end total to reach $10.5B. US investors now provide 47% of funding, up from 17% in 2020, with Accel, Founders Fund, General Catalyst, Lightspeed, and Y Combinator most active. Germany leads with $3.5B, driven by Munich firms Helsing ($1.8B round, $18B valuation) and Quantum Systems ($1.2B, $8B valuation). Defense tech now represents 11.1% of European VC, up from 4%. However, mega-rounds dominate (>85% of funding), exits remain scarce, and procurement hurdles persist in Germany and Britain.
- European defense tech startups raised $7.4B in VC in 2026, nearly triple 2025's $2.6B.
- US investors now provide 47% of funding, up from 17% in 2020.
- Germany leads with $3.5B raised, including Helsing's $1.8B round and Quantum Systems' $1.2B round.
Vitruvian Partners
Recent Signals
- ·techcrunchFunding
Angle Health raises $600M at $2.7B valuation
Health insurance startup Angle Health announced a $200 million Series C round and a $400 million tender offer, giving the company a $2.7 billion valuation. The round was led by Vitruvian Partners with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The tender offer permits employees to cash out shares, and the transaction is expected to close later this month. Angle Health, a Winter 2020 Y Combinator alum, helps small businesses manage level-funded health plans, offering a middle ground between fully insured and self-funded options. The company's AI-powered platform integrates with payroll and HR systems, serves over 5,000 businesses, and is reportedly profitable. This funding round is notable as it comes from a non-AI-agent startup founded in 2019.
- Angle Health raised a $200 million Series C round.
- The funding round included a $400 million tender offer.
- The company's valuation is now $2.7 billion.
- ·AdweekAgentic Advertising
DeepIntent launches agentic ad platform Cora for pharma marketing
DeepIntent, a healthcare-focused adtech firm, has launched Cora, an AI-powered agentic advertising platform designed for pharmaceutical marketers. The platform uses multiple AI agents to handle campaign planning, audience strategy, and media execution, including linear TV via a VideoAmp integration. Cora aims to speed up marketing workflows, with beta tests showing a 50% reduction in planning cycles and over 95% of clients reporting faster processes. This launch follows DeepIntent's majority stake sale to Vitruvian Partners, which provided $637 million to develop AI tools. The company targets the growing complexity of pharma marketing, especially for niche drugs targeting small patient populations. Cora is also powered by Helix, a data application providing aggregated healthcare data, including payer signals and drug coverage insights.
- DeepIntent launched Cora, an agentic ad platform for pharma marketing.
- Cora uses AI agents for campaign planning, audience targeting, and execution.
- Cora integrates with VideoAmp for linear TV campaign execution.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Founders Fund and Vitruvian Partners share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks